Firstly, the Journal of Clinical & Experimental Nephrology would like to pay tribute to the selfless and unconditional service that has been rendered by the medical fraternity particularly the frontline healthcare workers in this Pandemic to save several people placing their own lives at risk.

Healthcare workers have an elevated risk of developing coronavirus infection and high chance of transmitting it to their patients. Patients with kidney disease in need of dialysis or following a kidney transplant are very much at risk of death following COVID-19 due to the weakened immunity caused by immunosuppressive drugs.

Nephrology workers caring for patients with CKD are not uniformly positive for the virus in antibody tests unlike the findings obtained for COVID-19 patients. The researchers aimed to detect the prevalence of the infection through serologic testing for past COVID-19. They switched to antibody testing to get evidence of previous infection with the virus instead of reverse transcriptase-polymerase chain reaction (RT-PCR), which picks up immediate infection. The increasing tendency to rely on single antibody testing has no acceptable sensitivity to estimate the seroprevalence of large populations of asymptomatic people.

Journal of Clinical & Experimental Nephrology focuses on the dissemination of the latest  advancements on the current knowledge on all the aspects of Nephrology such as Peritoneal Dialysis, Kidney Diseases, Acute Renal Replacement Therapy, Chronic Kidney Disease, End-Stage Renal Diseases, Lupus Nephritis and Renal Transplantation.

Regards,

Calvin Parker
Journal of Clinical & Experimental Nephrology
WhatsApp: +32-2-808-66-57
E-mail id: nephrology@peerjournal.org